HUMAN MESENCHYMAL STEM CELLS AS BASIC TOOLS FOR TISSUE ENGINEERING: ISOLATION AND CULTURE



Similar documents
Basic Science in Medicine

Mesenchymal Stem Cells

Human Umbilical Cord-derived Multipotent Mesenchymal Stromal Cells (huc-msc) Handling Instructions

Human Umbilical Cord Blood CD34 + Progenitor Cell Care Manual

Comparison of Mesenchymal Stem Cells derived from Amniotic Fluid and Umbilical Cord

Minimal residual disease detection in Acute Myeloid Leukaemia on a Becton Dickinson flow cytometer

Equine Stem Cells. Sources, Processing, Expansion, Storage and Shipping

3D Cell Culture mimsys G

PROTOCOL. Immunostaining for Flow Cytometry. Background. Materials and equipment required.

Stem cells possess 2 main characteristics: Sources of pluripotent stem cells: -Long-term self renewal. -The inner cell mass of the blastocyst.

Chondrogenical Differentiation of Umbilical Cord Lining. Stem Cells

Transfection reagent for visualizing lipofection with DNA. For ordering information, MSDS, publications and application notes see

Processing & Utilization of Cord Blood for Transplant

Human Adult Mesothelial Cell Manual

PROTOCOL. Immunocytochemistry (ICC) MATERIALS AND EQUIPMENT REQUIRED

MEF Starter Nucleofector Kit

MEF Nucleofector Kit 1 and 2

BioResearch. Hematopoietic and Immune Cell Products Essential Tools for Hematopoietic Research

International Beryllium Conference, Montreal, Canada March 10, 2005

Osteoblast Differentiation and Mineralization

Evaporation-based Microfluidic Production of. Oil-free Cell-Containing Hydrogel Particles

NCL Method ITA-14. Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro

Instructions. Torpedo sirna. Material. Important Guidelines. Specifications. Quality Control

Application Note 10. Measurement of Cell Recovery. After Sorting with a Catcher-Tube-Based. Cell Sorter. Introduction

Human CD4+T Cell Care Manual

GASTRIC ORGANOID CULTURE PROTOCOL

How To Expand Hematopoietic Stem Cells

Poietics human mesenchymal stem cells Instructions for use

CFSE Cell Division Assay Kit

STEMCELL Quality Control Kits

BD PuraMatrix Peptide Hydrogel

NCL Method ITA-6. Leukocyte Proliferation Assay

Cord Blood Re-imagined The use of cord blood stem cells for clinical applications and medical innovations

HARVESTING AND CRYOPRESERVATION OF HUMAN EMBRYONIC STEM CELLS (hescs)

Follicle Dermal Papilla Cell

Cellartis Protocol Culturing of hes Cells

Optimized Protocol sirna Test Kit for Cell Lines and Adherent Primary Cells

Role Of Mitochondria In Mesenchymal Stem Cells

CHARACTERISTIC FEATURES OF STEM CELLS. CLONING TECHNOLOGIES

Ficoll-Paque PREMIUM Ficoll-Paque PREMIUM Ficoll-Paque PREMIUM 1.073

Human Peripheral Blood Mononuclear Cell (PBMC) Manual

Hoechst HSC Staining and Stem Cell Purification Protocol (see Goodell, M., et al. (1996) J Exp Med 183, )

Introduction to Flow Cytometry

Islet Viability Assessment by Single Cell Flow Cytometry

Fast, easy and effective transfection reagent for mammalian cells

RPCI 004 v.002 Staining Procedure For all Directly Conjugated Reagents (Whole Blood Method)

Amaxa Mouse T Cell Nucleofector Kit

Enumeration and Viability of Nucleated Cells from Bone Marrow, Cord Blood, and Mobilized Peripheral Blood

The Prospect of Stem Cell Therapy in Multiple Sclerosis. Multiple sclerosis is a multifocal inflammatory disease of the central

5 Frequently Asked Questions About Adult Stem Cell Research

No-wash, no-lyse detection of leukocytes in human whole blood on the Attune NxT Flow Cytometer

The Therapeutic Potential of Human Umbilical Cord Blood Transplantation for Neonatal Hypoxic-Ischemic Brain Injury and Ischemic Stroke

低 剂 量 辐 射 对 脐 血 T 淋 巴 细 胞 膜 分 子 表 达 的 影 响 EFFECT OF LOW DOSE IRRADIATION ON EXPRESSION OF MEMBRANE MOLECULES OF T LYMPHOCYTES IN CORD BLOOD

Generation of EBV-immortalized B cell lines

Amaxa 4D-Nucleofector Protocol for Mouse Embryonic Stem [ES] Cells For 4D-Nucleofector X Unit Transfection in suspension

Bio Deutschland CEO & CFO-Meeting 29. November Unternehmertum in den Life Sciences am Beispiel der Geschichte von Miltenyi Biotec

Standard Operating Procedures (SOPs) for the production and testing of embryonic stem cell lines in Taiwan Stem Cell Bank

STEM CELL FELLOWSHIP

TERUMO Corporation Business Strategy Conference

OriginalArticle. Critical Parameters for the Isolation of Mesenchymal Stem Cells from Umbilical Cord Blood

protocol handbook 3D cell culture mimsys G hydrogel

EVALUATION OF THE EFFECT OF THE COMPOUND RIBOXYL ON THE ATP LEVEL AND CELLULAR RESPIRATION FROM HUMAN DERMAL FIBROBLASTS

Stem Cell Research: Adult or Somatic Stem Cells

STEM CELL FACTS. The ISSCR is an independent, nonproft organization providing a global forum for stem cell research and regenerative medicine.

HyStem. Hydrogels CELLULAR MATRICES FOR TRANSLATIONAL RESEARCH. esibio.com

Human Hepatic Sinusoidal Endothelial Cell Manual

Lab 2. Isolation of mononuclear cells from peripheral blood and separation into subpopulations

Stem Cell Quick Guide: Stem Cell Basics

RITMIR024 - STEM CELL RESEARCH IN CARDIOLOGY

WHOLE BLOOD LYSING SOLUTION FOR FLOW CYTOMETRIC APPLICATIONS

S YN T H E T I C C A N C E L LO U S B O N E

Biotechnology. Srivatsan Kidambi, Ph.D.

Especially developed for the transfection of mammalian cells with sirna or mirna

Radius 24-Well Cell Migration Assay (Laminin Coated)

CytoSelect 48-Well Cell Adhesion Assay (ECM Array, Fluorometric Format)

San Diego Stem Cell Treatment Center Frequently Asked Questions

EdU Flow Cytometry Kit. User Manual

Cultivation and Cryopreservation of Cord Tissue MSCs with Cord Blood AB Plasma

CD34+ CD45- Cells Isolated from Human Blood Have Molecular and Functional Characteristics of Vascular Endothelial Progenitors

guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research

STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE

Chapter 16 Reproductive Technology, Gene Therapy, and Stem Cells (modified)

Stem Cells. Part 1: What is a Stem Cell?

Animal Cell Culture. Third Edition. A Practical Approach OXJORD VNIVVRSITY 1'RVSS

Below is a list of things you should be aware of before you schedule your sort.

Expression of CD163 on Bovine Alveolar Macrophages and Peripheral Blood Mononuclear Cells

Measuring Cell Viability/Cytotoxicity: Cell Counting Kit-F

14.0 Stem Cell Laboratory Services

APPLICATION INFORMATION

Analyzing Samples for CD34 Enumeration Using the BD Stem Cell Enumeration Kit

The Types of stem cells: Totipotent Pluripotent Multipotent

Utility of flow cytometric κ and λ light chain analysis of peripheral blood

Enhance Sensitivity of FISH Analysis with Highly Purified Multiple Myeloma Cells Using RoboSep, the Fully Automated Cell Separator

Transcription:

HUMAN MESENCHYMAL STEM CELLS AS BASIC TOOLS FOR TISSUE ENGINEERING: ISOLATION AND CULTURE MONICA NEAGU*, ERIKA SUCIU**, VALENTIN ORDODI**, VIRGIL PĂUNESCU** *Department of Biophysics and Medical Informatics, Victor Babeş University of Medicine and Pharmacy Timişoara, 2, P-Ńa E. Murgu, 300041 Timişoara, Romania **Department of Physiology and Immunology, Victor Babeş University of Medicine and Pharmacy Timişoara, 2, P-Ńa E. Murgu, 300041 Timişoara, Romania Abstract. Stem cells are immature cells capable of autoreplication, which are able to generate various mature cell types and have a remarkable viability and proliferative capacity. Mesenchymal stem cells (MSC), under proper conditions, can give rise to osteoblasts, adipocytes, chondrocytes, myocytes and even neurons. Several procedures applied in tissue engineering imply harvesting autologous MSC, expanding them in culture without loss of stemness, inducing differentiation, seeding them on suitable scaffolds in accordance with the targeted tissue type and implanting the construct into the patient s body. During this study, bone marrow has been extracted from 9 patients by aspiration from the upper posterior iliac crest and used in order to isolate the MSC by employing three different methods: (1) the Ficoll-Paque technique for the isolation of mononucleated cells followed by the separation of MSC by adherence to plastic, (2) Ficoll-Paque followed by the immuno-magnetic separation of MSC using a CliniMACS system and (3) a negative selection procedure of MSC using the RosetteSep technique followed by adherence to plastic. We have prepared and optimized our media, assuring control and reproducibility of the results. Finally, an immunophenotypic characterization of the cells by flowcytometry has been performed. On the 3 rd day after seeding the isolated mononucleated fraction in the optimally prepared culture medium, we observed elongated adherent cells which have undergone extensive proliferation between days 5 and 9, with colony forming around days 10 to 14. The cell population reached 70 80% confluence within 3 weeks in culture. Independent on the isolation procedure, the largest number of cell colonies has been obtained for a cell seeding density of 10 6 cells/cm 2. Key words: stem cells, differentiation, plasticity, flowcytometry. Received July 2005; in final form October 2005. INTRODUCTION In the case of tissue damage, transplant is one of the very few clinical solutions available today. Nevertheless, its feasibility is limited by donor organ shortage. In an effort to circumvent this problem, about two decades ago a new field of medical sciences emerged, which goes by the name of tissue engineering (TE) and aims to develop biologically based replacement tissues. Several problems must be solved before TE is used on large scales in clinical practice. These include ROMANIAN J. BIOPHYS., Vol. 15, Nos. 1 4, P. 29 34, BUCHAREST, 2005

30 Monica Neagu, Erika Suciu, V. Ordodi, V. Păunescu questions regarding a suitable cell source, the identification of the appropriate scaffold for each tissue type of interest and the optimization of the culture conditions in order to ensure viability and physico-chemical properties comparable to the native organ. Stem cells (SC) are immature cells with two essential features: (1) they are capable of autoreplication and (2) they are able to give rise to various mature cell types of the organism. In culture, they have a remarkable viability and proliferative capacity [1, 2]. All these characteristics make them a favourite cell source for TE. The bone marrow is regarded as the most important non-hemopoietic, mesenchymal stem cell (MSC) source. MSCs have been identified in the periosteum, muscle, liver, blood and fetal bone marrow, whereas their occurrence in the umbilical cord blood is controversial. By supplementing the cell culture medium with specific growth and differentiation factors, MSC may be coaxed to give rise to osteoblasts, chondrocytes, myocytes, adipocytes, cardiomyocytes and neurons, too [7]. In order to use MSC in regenerative medicine, it is necessary to isolate and proliferate them without loss of stemness, i.e. preserving their pluripotentiality and proliferative capacity in undifferentiated state. Recent studies are focused on developing optimal culture conditions (including cell culture media, bioactive agents and biodegradable scaffolds) for each specific therapy [9]. MATERIALS AND METHODS PATIENTS Bone marrow from 9 patients (10 ml/patient) has been extracted from the upper posterior iliac crest using a heparinated syringe, under general anesthesia, in a sterile surgical room, in accordance with ethical regulations and having the acceptance of the patients. CELL SEPARATION We employed three methods of isolation of MSC from bone marrow: (1) the Ficoll-Paque technique for the isolation of mononucleated cells followed by the separation of MSC by adherence to plastic, (2) Ficoll-Paque followed by the immuno-magnetic separation of MSC and (3) a negative selection procedure of MSC using the RosetteSep technique, followed by adherence to plastic. 1. The Ficoll-Paque technique of density gradient centrifugation was employed by first diluting the bone marrow sample with cell culture medium supplemented with 2% PBS and 1 2 mm EDTA; the resulting solution was poured on the top of the separation medium (Ficoll-Paque solution of 1.077 g/ml density), in a 50 ml centrifuge tube (Becton Dickinson, USA) and centrifuged at room

Isolation and culture of hmsc 31 temperature, at 445 g, for 35 minutes. The majority of the mononucleated cells accumulated on the Ficoll-plasma interface. The centrifugation was repeated for 10 minutes at 300 g. Finally, the cells were resuspended and counted using a hemocytometer. 2. RosetteSep combines the density gradient separation with antibodymediated specificity. The bone marrow was placed into a centrifuge tube (Becton Dickinson, USA) and, after adding the RosetteSep solution, the mixture was incubated at room temperature for 20 minutes and centrifuged for 25 minutes at 300 g. The result was a negative selection of MSC, which have not been targeted by antibodies and accumulated on the plasma-ficoll interface. The mononuclear cell suspension obtained by Ficoll or RosetteSep separation technique was plated on Petri dishes for selective isolation by adhesion. The cells were incubated at 37 o C, in 5% CO 2 and 95% minimal humidity at different seeding densities: 5, 10, 15, 50, 100 and 500 x 10 4 cells/cm 2. The non-adherent cells were eliminated on the 3 rd day after seeding by replaceing the culture medium. The adherent cells were cultured until 70 80% confluence was attained (14 21 days) with medium change every 4 th day. 3. Isolation using MACS Direct CD105 consists in magnetic sorting of CD105+ cells. To this end, we used a MidiMACS Separator (Miltenyi Biotec, Germany). The cells were immunomagnetically labeled using a cell-type specific reactive. The suspension obtained by the Ficoll technique was mixed with MACS CD105 superparamagnetic colloidal MicroBeads, (Miltenyi Biotec, Germany) coated with CD105 monoclonal antibodies: and incubated for 15 minutes at 6-12 C. The magnetically labeled separated cells were used in part for flowcytometric and viability analyses, the rest being cultured. CELL CULTURE We used Dulbecco s Modified Eagle s Medium (DMEM) low glucose (Sigma-Aldrich, Germany), supplemented with 10% Fetal Calf Serum (FCS) (Promocell, Germany), 2 ng/ml FGFb (Sigma-Aldrich, Germany) and 1% antibiotic/antimycotic (penicillin 10.000 u/ml; streptomycin 10 mg/ml; amfoterycin B 0,25 µg/ml) (Sigma-Aldrich, Germany). The cells were plated on T25 culture dishes (Becton Dickinson, USA) at 6 values of the seeding density, and incubated at 37 C in an atmosphere of 95% relative humidity and 5% CO 2. The first medium change was done 72 h after seeding, then medium was changed weekly. For passage, the medium was discarded, the system was washed with PBS, cells were detached using trypsin/edta 0,25%. After trypsin neutralization with DMEM supplemented with 10% FBS, the cell suspension was centrifuged at room temperature for 10 minutes at 300 g, the supernatant was removed and the cells were resuspended, counted and distributed in culture dishes.

32 Monica Neagu, Erika Suciu, V. Ordodi, V. Păunescu FLOWCYTOMETRIC ANALYSIS The cells have been phenotypically characterized by using a flowcytometer (FACSCalibur, Beckton Dickinson). After trypsinization, 100.000 cells were incubated with fluorescence-conjugated antibodies (marked with FITC fluorescein isothiocyanate and PE phycoerythrin fluorochromes, Beckton Dickinson) for 20 min in the dark. After 2 washing steps with PBS, cells were acquired in FACSCalibur (Becton Dickinson) flowcytometer using CellQuest software and analysed with Paint-A-Gate software. RESULTS We harvested human bone marrow from 9 patients, made a comparative study of three isolation techniques, cultivated and analysed the MSC and performed a morphological characterization together with a flowcytometric analysis of the cells. Fig. 1. Mesenchymal stem cells on day 14 (left, 200x magnification), and on day 21 after seeding, respectively (right, 40x magnification). On the 3 rd day after seeding we observed elongated adherent cells; these have undergone extensive proliferation between days 5 and 9, with colony formation around day 10 to 14. The cell population reached confluence within 3 weeks in culture. During long-term cultivation, cells were passed after 2 weeks from seeding, at 70 80% confluence, and were examined during 8 weeks. The initial flowcytometric analysis, performed on day 0 when cells were seeded, displayed a heterogeneous mixture of cells with different forward and sideward scattering profiles (data not shown). A major proportion of the cells expressed CD45 and Glycophorin A, while the specific MSC markers, CD105 and CD73 were not expressed. The immunophenotype of the cells resulted from passage 1 (day 21) showed low levels of CD14, Glycophorin A and CD45, probably due to contaminating cells (data not shown). The flowcytometric analysis revealed a significant increase of CD 73 expression at the second passage (day 42).

Isolation and culture of hmsc 33 The hemopoietic stem cell marker, CD34, was not expressed neither on day 0, nor after the two passages. The data have been displayed in the form of single-colour histograms, evidencing the CD34, CD45, CD90, CD105 and CD73 expression by the investigated cells (Fig. 2). Fig. 2. Immunophenotypic characterization of the cells by FACS analysis, on day 42 after seeding (passage 2). Each plot is a histogram depicting the number of cells vs. their fluorescence level. The numbers specify the percentage of cells expressing the specific markers (with fluorescence falling between the marker boundaries, marked by the horizontal segments). DISCUSSIONS During the past two decades MSC have been extensively investigated because of their far reaching therapeutic potential [10, 11]. From the point of view of cell and gene therapies, they display several exciting properties such as ease of isolation, good proliferative capacity and ease of transfection with exogeneous genes. Several procedures proposed for tissue repair imply harvesting autologous mesenchymal stem cells, expanding them in culture, inducing differentiation, seeding them on suitable scaffolds in accordance with the targeted tissue type and implanting the construct into the patient s body [4, 6, 8]. The composition of the cell culture medium turned out to be a decisive factor in preserving the stem cell features [5, 9]. Under certain conditions MSC may be passed 25 30 times without observing signs of spontaneous differentiation. Yet other conditions coax MSC to engage towards one of several cell lineages; this property goes by the name of stem cell plasticity [3, 7].

34 Monica Neagu, Erika Suciu, V. Ordodi, V. Păunescu Human MSC isolated in our laboratories have expressed typical cell surface markers at levels in good agreement with recent results of similar studies. A typical MSC marker, CD105, displayed a slight regression from day 21 to day 42, presumably due to spontaneous differentiation of the cells, while the expression of CD90 and CD73 showed a significant increase. However, even after 42 days, 36,56% of the cells express CD105, 86,52% express CD73 and 66,32% express CD90 suggesting that their stemness has been preserved. By comparing the mean number of formed colonies, counted during all 21 performed experiments, no significant differences in colony formation between the three distinct MSC isolation methods have been observed (data not shown). This comparison allowed us to find the optimal cell seeding density (10 6 cells/cm 2 ) which assured a maximal number of colonies. These observations enable us to conclude that the cell culture media and conditions were suitable for MSC expansion. Future work will be focused on human MSC differentiation in vitro towards the osteogenic and chondrogenic lineages. Acknowledgements. This work was supported by Grant VIASAN nr. 313 / 2004. from the National Research, Development and Innovation Program (PNCDI). R E F E R E N C E S 1. BIANCO, P., M. RIMINUCCI, S. GRONTHOS, P.G. ROBEY, Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells, 2001, 19, 180 192. 2. COMPSTON, J.E., Bone marrow and bone: a functional unit, Journal of Endocrinology, 2002, 173, 387 394. 3. CONGET, P.A., J.J. MINGUELL, Phenotypic and functional properties of human bone marrow mesenchymal progenitor cells, J. Cell Physiol., 1999, 181, 67 73. 4. DOMINICI, M., T.J. HOFMANN, E.M. HORWITZ, Bone marrow mesenchymal cells: biological properties and clinical applications, Journal of Biological regulators and Homeostatic Agents, 2002, 15, 28 37. 5. FRIEDENSTEIN, A.J., R.K. CHAILAKHYAN, U.V. GERASIMOV, Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers, Cell Tissue Kinet, 1987, 20, 263 272. 6. HUNG, S.-C., N.-J. CHEN, S.-L. SHIEH, H. LI, H.-L. MA, W.-H. LO, Isolation and Characterization of size-sieved stem cells from human bone marrow, Stem Cells, 2002, 20, 249 258. 7. KRAUSE, D.S., Plasticity of marrow-derived stem cells. Gene Therapy, 2002, 9, 754 758. 8. LANGER, R., J.P. VACANTI, Tissue engineering, Science, 1993, 260, 920 926. 9. MAJUMDAR, M.K., M.A. THIEDE, J.D. MOSCA, M. MOORMAN, S.L. GERSON, Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells, J. Cell Physiol., 1998, 176, 57 66. 10. PITTENGER, M.F., A.M. MACKAY, S.C. BECK, R.K. JAISWAL, R. DOUGLAS, J.D. MOSCA, M.A. MOORMAN, D.W. SIMONETTI, S. CRAIG, D.R. MARSHAK, Multilineage potential of adult human mesenchymal stem cells, Science, 1999, 284, 143 147. 11. ZIKUAN, G., Y. JINGQUING, L. XIAODAN, L. XIUSEN, H. CHUNMEI, T. PEI HSEIN, M. NING, Biological features of mesenchymal stem cells from human bone marrow. Chin. Med. J., 2001, 114, 950 953.